Sector Alpha Week of 2026-08-14
Sector Alpha — machine-written from the numbers · Data as of 2026-08-14

Take Solutions Ltd

TAKE
Miscellaneous

Take Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.

Biggest watch item: the P/E sits at the 100th percentile of its own range — the multiple has already done part of the work.

The price is in a confirmed uptrend (29 weeks in) while the P/E sits at the 100th percentile of its own 10-year range. Underneath, the last four quarters read mixed — profit −97.7% year on year, and 55% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.

Price
₹43.6
+444.5% 1Y
P/E
3,222.0×
100th pctile
of its own 10-year range
Revenue (Dec 25)
₹0.0 Cr
Profit (Dec 25)
₹1.1 Cr
−97.7% YoY
ROCE
11%
FY25
ROIC
−6.6%
vs WACC 12.0% → −18.6 pp
Cash conversion
55%
of profit, last 3 FY
Unverified figures: Some figures on this page come from a second financial-data feed that could not be cross-checked against the primary source — the two do not share enough overlapping reported history to compare. They are drawn, because they are the only evidence there is, and every section carrying one is marked unverified. PEG is the exception: the quarterly curve is not drawn at all. PEG asks what is being paid for growth — both sides of that division come from the source that could not be checked, so it is withheld instead of marked.
01 · Price story

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Take Solutions Ltd trades at ₹43.6, in a confirmed uptrend and 29 weeks into that stage. That is +35.1% against its own 200-day average. It sits at 87% of a 52-week range of ₹7 to ₹49. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 45 straight weeks.

Today the stock is in a confirmed uptrend — week 29 of stage 2, confirmed. At ₹43.6 it trades +35.1% versus its 200-day average and sits at 87% of its 52-week range (₹7–₹49).

Apr 26: ₹43.6 Weekly closing price (₹) with 50- and 200-day averages; shaded bands mark the price stage (grey base, green advance, amber top, red decline). 3-year window.
+35.1% versus the 200-day line, week 29 of stage 2
Price50-day avg200-day avg
S4S2S4S2₹52.6₹40.2₹27.9₹15.6₹3.3₹44₹32Apr 23Jan 24Oct 24Jul 25Apr 26
S4S2S4S2₹52.6₹40.2₹27.9₹15.6₹3.3₹44₹32Apr 23Oct 24Apr 26
Beating or trailing, week by week since 2016 Each cell is one week from 2016 to now (532 weeks): the stock's trailing 13-week return minus the NIFTY 500's, green ahead / red behind (±25% ramp). Grey cells are the 13-week warm-up or weeks where the NIFTY 500 reading is not held.
trailing 13-week return vs the NIFTY 500
Feb 16Apr 26

Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved −67% while the NIFTY 500 moved +277% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 45 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

02 · Valuation

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Take Solutions Ltd trades at 3,222.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 13.4×, measured across 10.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 3,222.0× is about the priciest it has ever traded, against a long-run median of 13.4× measured over 10.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

P/E 3,222.0× vs a 13.4× long-run median P/E, weekly (left axis); earnings per share, trailing twelve months, weekly (right axis). 10.0-year window; loss-period spikes above 40× shown pinned at the top. The eps (ttm) bars are red where the reading is lower than the quarter before.
about the priciest it has ever traded
P/EMedianEPS (TTM) (quarterly)
43.1×₹15.132.5×₹11.321.8×₹7.511.1×₹3.80.5×₹0.0×40.20×₹0Feb 16Apr 17Jun 18Jul 19Feb 26
43.1×₹15.132.5×₹11.321.8×₹7.511.1×₹3.80.5×₹0.0×40.20×₹0Feb 16Jun 18Feb 26
P/E
3,222.0×
100th percentile of 10y

Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.

A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

03 · Stage: No read

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Take Solutions Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 1 curve, on partial evidence.

Growth, year by year: revenue −100.0% in FY25 Year-over-year growth per fiscal year, %: revenue (left axis); net profit and EPS (right axis — profit growth swings far wider). Zero line drawn.
Revenue YoYProfit YoYEPS YoY
52%86%11%34%−30%−18%−70%−70%−111%−121%%%−100%−106.1%FY15FY20FY25
52%86%11%34%−30%−18%−70%−70%−111%−121%%%−100%−106.1%FY15FY20FY25
Three growth curves, twelve quarters Year-on-year growth of trailing-twelve-month revenue (left axis), profit and EPS (right axis — they swing far wider), % at each quarter-end. Where the trailing-twelve-month history is short, the curve falls back to single-quarter year-on-year growth — noisier, and the classifier smooths and caps base-effect spikes before reading. A missing point means that reading is not held for the quarter.
the trajectory the stage is read from
RevenueProfit
−98.8%−96.5%−99.4%−97.1%−100.0%−97.7%−100.6%−98.3%−101.2%−98.9%%%−100%−97.7%Mar 23Jun 24Dec 25
−98.8%−96.5%−99.4%−97.1%−100.0%−97.7%−100.6%−98.3%−101.2%−98.9%%%−100%−97.7%Mar 23Jun 24Dec 25
ROCE Annual readings — the quarterly balance-sheet pieces this curve needs are not held for this stock, so the returns read moves once a year and carries less weight in the call.
the return curve, annual readings
ROCE
14%4.2%−5.5%−15%−25%%11.2%FY22FY23FY25
14%4.2%−5.5%−15%−25%%11.2%FY22FY23FY25
ROCE
Rising
latest 11.2% · span −22.2%–11.2%

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

Compound annual growth rate (%) Compound annual growth rate over each window, %. Revenue, profit and EPS from fiscal-year figures; share price is the price CAGR over the same spans. A dash = that window is not held, or the base was a loss.
1yr3yr5yr10yr
Profit−7.3%
EPS−7.8%
Share price+444.5%+40.4%−3.0%−10.2%
Profit YoY (Dec 25)
−97.7%
latest quarter vs a year ago
04 · 4-Factor Sector Score

4-Factor Sector Score

58.7/100 — rank 6 of 36 in Miscellaneous · 57% evidence confidence

Take Solutions Ltd scores 58.7 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 6. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

The four contributions add to the total exactly: 24.7 + 8.5 + 8.5 + 17 = 58.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

05 · Revenue

Revenue Revenue is the top line: everything the company billed its customers in the period.

Take Solutions Ltd reported ₹0.0 Cr of revenue in the Dec 25 quarter. The last full year, FY25, came in at ₹0.0 Cr. The last four reported quarters add to ₹0.0 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.

FY25 revenue came in at ₹0.0 Cr (−100.0% on the year). The latest quarter (Dec 25) printed ₹0.0 Cr, null year on year.

FY25 revenue ₹0.0 Cr (−100.0% YoY) Revenue bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
RevenueYoY growth
2.4k52%1.8k11%1.2k−30%597−70%0−111%₹ Cr%₹0−100%FY15FY20FY25
2.4k52%1.8k11%1.2k−30%597−70%0−111%₹ Cr%₹0−100%FY15FY20FY25
Dec 25: ₹0.0 Cr (null YoY) Quarterly revenue bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Revenue (quarterly)YoY growth
41−99.89%30−99.92%20−99.95%10−99.98%0−100.01%₹ Cr%₹0−100%Mar 23Jun 24Dec 25
41−99.89%30−99.92%20−99.95%10−99.98%0−100.01%₹ Cr%₹0−100%Mar 23Jun 24Dec 25
06 · Operating margin

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

A clean operating margin is not in our numbers for Take Solutions Ltd — its accounts do not report the operating-profit line this section reads, which is common for lenders and holding companies. The sections above and below carry the readings this company's filings do support.

This company's accounts do not report the operating-profit line this section reads — common for lenders and holding companies classified outside the financial bucket. The revenue and net-profit sections are the cleaner reads for Take Solutions Ltd.

🚨 Why the margin moved: operating margin went −2,839.1 pp year on year while gross margin went +47.9 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.

FY25: −227.8% Operating margin by fiscal year, %, line (left); year-on-year change in the margin, in percentage points, line (right). 12-year window.
within a −568.9–20.7% band over 12 years
operating marginYoY change (pp)
68%413%−103%152%−274%−109%−445%−370%−616%−631%%%−227.8%341.1%FY14FY19FY25
68%413%−103%152%−274%−109%−445%−370%−616%−631%%%−227.8%341.1%FY14FY19FY25
Dec 25: null% operating margin (null pp YoY) Quarterly operating margin, %, line (left); year-on-year change in the margin, in percentage points, line (right). Last 12 quarters. Operating profit as a share of revenue, per quarter.
Operating marginYoY change (pp)
267%3,398%−584%1,709%−1,434%0.0%−2,284%−1,669%−3,135%−3,358%%%32.2%2,932.2%Mar 23Jun 24Dec 25
267%3,398%−584%1,709%−1,434%0.0%−2,284%−1,669%−3,135%−3,358%%%32.2%2,932.2%Mar 23Jun 24Dec 25
07 · Net profit

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Take Solutions Ltd earned ₹1.1 Cr of net profit in the Dec 25 quarter, −97.7% year on year. Full-year FY25 profit was ₹37.5 Cr. The 10-year compound rate is −7.3%. The same quarter a year earlier earned ₹47.7 Cr. 9 of the last 12 reported quarters were loss-making.

Dec 25 profit was ₹1.1 Cr, −97.7% year on year. On the full year, FY25 printed ₹37.5 Cr (null), and the 10-year compound rate is −7.3%.

FY25 profit ₹37.5 Cr (null YoY) Net profit bars, ₹ Cr (left); YoY growth-% line (right). 11-year window. A bar is red when it is lower than the year before.
−7.3% a year over 10 years
Net profitYoY growth
25569%−2322%−302−25%−581−72%−859−119%₹ Cr%₹37−106.1%FY15FY20FY25
25569%−2322%−302−25%−581−72%−859−119%₹ Cr%₹37−106.1%FY15FY20FY25
Dec 25: ₹1.1 Cr (−97.7% YoY) Quarterly net profit bars, ₹ Cr (left); YoY growth-% line (right). Last 12 quarters. A bar is red when it is lower than the quarter before.
Net profit (quarterly)YoY growth
60−96.5%14−97.1%−31−97.7%−77−98.3%−123−98.9%₹ Cr%₹1−97.7%Mar 23Jun 24Dec 25
60−96.5%14−97.1%−31−97.7%−77−98.3%−123−98.9%₹ Cr%₹1−97.7%Mar 23Jun 24Dec 25
08 · Cash flow — the router

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 55% of Take Solutions Ltd's reported profit arrived as operating cash — a gap worth watching. In FY25 that was ₹−16.4 Cr of operating cash against ₹37.5 Cr of profit. After ₹−30.0 Cr of capital spending, ₹14.0 Cr was left as free cash.

FY25: operating cash of ₹−16.4 Cr against reported profit of ₹37.5 Cr, leaving free cash of ₹14.0 Cr after ₹−30.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 55% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

FY25: CFO ₹−16.4 Cr vs profit ₹37.5 Cr Operating cash flow and net profit by fiscal year, ₹ Cr; the line is free cash flow (CFO minus capital spending). 11-year window, annual resolution. FY19 reflects an acquisition year — point shown clipped.
55% of 3-year profit arrived as cash
Operating cashNet profitFree cash
9054520−454−907₹ Cr₹−16₹37₹14FY15FY20FY25
9054520−454−907₹ Cr₹−16₹37₹14FY15FY20FY25
FY25: CFO = −44% of profit (three-year rate 55%) Operating cash as a share of net profit, per fiscal year, % (line). Dashed line = 100% — every unit of profit arriving as cash.
Conversion100%
134%86%39%−9.3%−57%%−44%FY15FY20FY25
134%86%39%−9.3%−57%%−44%FY15FY20FY25

🚨 Why conversion sits at 55%: the cash cycle tightened 116 days between FY20 and FY25 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.

Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.

09 · Where the cash goes

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Take Solutions Ltd's cash conversion cycle runs 0 days in FY25, down from 116 days in FY20. Capital spending ran ₹−87.0 Cr over the last 3 years.

FY25: debtors at 0 days (an asset-light business — no inventory to speak of) — for a full cycle of 0 days, tighter than FY20's 116.

FY25: a 0-day cash cycle Debtor days, inventory days, payable days and the cash conversion cycle by fiscal year. 12-year window.
−116 days vs FY20
Cash cycleDebtor days
772565357150−57days0d0dFY14FY16FY19FY22FY25
772565357150−57days0d0dFY14FY19FY25

On the investment side: capital spending of ₹−87.0 Cr over the last 3 fiscal years against ₹18.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.

FY25: capex ₹−30.0 Cr, work-in-progress ₹0.0 Cr Capital spending per fiscal year, ₹ Cr (bars); capital work-in-progress, ₹ Cr (line). Quarterly capital-spending history is not held for India — annual is the honest resolution.
steady investment
CapexWork-in-progress
767360−48−455−862₹ Cr₹−30₹0FY15FY17FY20FY22FY25
767360−48−455−862₹ Cr₹−30₹0FY15FY20FY25

The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.

10 · Return on capital

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Take Solutions Ltd earns a ROCE of 11% in FY25. That is up from a trough of −22% in FY24. Return on invested capital clears the cost of that capital by −18.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −3,322.8% net margin on 0.04× asset turns.

FY25 ROCE is 11%, recovered from a FY24 trough of −22% — the full ladder below shows the fall and the climb, undoctored.

🚨 Why the return is what it is — the wiring (FY24): −3,322.8% net margin × 0.04× asset turns × −9.92× balance-sheet leverage ≈ 1,318.5% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: −6.6% − 12.0% = a −18.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.

FY25: ROCE 11% Return on capital employed by fiscal year, % (line); ROIC by fiscal year, % (line). 12-year window, dips included. Dashed line = the 12.0% cost of capital used on this page.
the climb back from FY24's −22%
ROCEROIC (annual)WACC
25%−6.4%−38%−70%−101%%11.2%−92.7%FY14FY19FY25
25%−6.4%−38%−70%−101%%11.2%−92.7%FY14FY19FY25
Q4 FY26: ROCE −7.2% (TTM) vs WACC 12.0% Trailing-twelve-month ROCE and ROIC, per quarter, %; dashed line = the cost of capital. Last 12 quarters, put on a trailing-twelve-month basis and anchored to the annual figure.
ROCE (TTM)ROIC (TTM)WACC
36%14%−9.4%−32%−55%%−7.2%−13.7%Q2 FY23Q4 FY24Q4 FY26
36%14%−9.4%−32%−55%%−7.2%−13.7%Q2 FY23Q4 FY24Q4 FY26
11 · Debt

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Take Solutions Ltd's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from 0.43 in FY22 to −4.11 in FY24. The returns elsewhere on this page are therefore earned rather than borrowed.

Dec 24: total debt of ₹8.0 Cr against shareholder equity of ₹−14.0 Cr — a debt-to-equity of −0.57. On the annual view, debt-to-equity went from 0.43 (FY22) to −4.11 (FY24). The returns on this page are earned, not borrowed.

FY24: debt ₹37.0 Cr at −4.11× equity Total debt by fiscal year, ₹ Cr (bars); debt-to-equity, × (line). 3-year window.
Total debtDebt-to-equity
840.8×63−0.5×42−1.8×21−3.2×0−4.5×₹ Cr×₹37−4.11×FY22FY23FY24
840.8×63−0.5×42−1.8×21−3.2×0−4.5×₹ Cr×₹37−4.11×FY22FY23FY24
Dec 24: debt ₹8.0 Cr, debt-to-equity −0.57 Total debt per quarter, ₹ Cr (bars); debt-to-equity, × (line). Last 12 quarters. India reports the full balance sheet half-yearly, so the intervening quarter carries the prior reading forward.
Total debt (quarterly)Debt-to-equity
840.8×63−0.5×42−1.8×21−3.2×0−4.5×₹ Cr×₹8−0.57×Mar 22Jun 23Dec 24
840.8×63−0.5×42−1.8×21−3.2×0−4.5×₹ Cr×₹8−0.57×Mar 22Jun 23Dec 24
12 · Ownership

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Promoters cut 53.4 points of Take Solutions Ltd over 8 quarters, the biggest move on the register. That takes promoters to 0.0% of the company. Foreign institutions moved +0.3 points over the same window, to 0.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Promoters: −53.4 points over 8 quarters to 0.0%; Foreign institutions: +0.3 points over 8 quarters to 0.3%; Domestic institutions: +0.0 points over 8 quarters to 0.0%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.

🚨 Why the register moved: promoters drove it (−53.4 points) — distribution into the market’s bid.

Fiscal-year ends: promoters −53.4 pts from Mar 23 to Mar 26 Shareholding at each fiscal-year end (March quarter), % of the company. 4 year-ends held.
PromotersForeign inst.Domestic inst.Public
108%79%50%21%−8.0%%0%0.3%0%99.7%Mar 23Mar 24Mar 26
108%79%50%21%−8.0%%0%0.3%0%99.7%Mar 23Mar 24Mar 26
Promoters cut 53.4 points over 8 quarters Shareholding by holder class, % of the company, quarterly, last 13 quarters.
PromotersForeign inst.Domestic inst.Public
108%79%50%21%−8.0%%0%0.3%0%99.7%Mar 23Sep 24Mar 26
108%79%50%21%−8.0%%0%0.3%0%99.7%Mar 23Sep 24Mar 26
13 · Safety line

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Take Solutions Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.

The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.

14 · Related companies · Miscellaneous
CompanyScorePrice stageGrowth & earnings/35Capital efficiency/25Valuation/20Relative strength/20
1Gulshan Polyols LtdGULPOLY 74.3/100Favorable setup87% evidence ASLEEP 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence 19.1/25 ROCE 18.3% · OPM 13% 95% evidence 13.1/20 P/E 8× · PEG — 50% evidence 14.6/20 RS sector 13.6% · RS bench 12.7% · 1Y 8.5%8 of 12 weeks ahead 100% evidence
Exact sum: 27.5 + 19.1 + 13.1 + 14.6 = 74.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence.
2Sagility LtdSAGILITY 66.2/100Favorable setup87% evidence BASING 24.7/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence 15.8/25 ROCE 13.4% · OPM 22% 100% evidence 13.9/20 P/E 19.3× · PEG 1.02 65% evidence 11.8/20 RS sector 7.2% · RS bench -7.7% · 1Y -6.4%0 of 10 weeks ahead 70% evidence
Exact sum: 24.7 + 15.8 + 13.9 + 11.8 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
3IIRM Holdings India Ltd526530 64.4/100Mixed-positive evidence75% evidence LEADER 16.3/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence 19.0/25 ROCE 20.4% · OPM 24.6% 76% evidence 9.8/20 P/E 37.2× · PEG — 15% evidence 19.3/20 RS sector 40% · RS bench 38.6% · 1Y 71.7%12 of 12 weeks ahead 100% evidence
Exact sum: 16.3 + 19 + 9.8 + 19.3 = 64.4 · Decision use: Price leads the evidence: RS versus the benchmark is 38.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
4Exhicon Events Media Solutions Ltd543895 63.4/100Thin evidence · provisional60% evidence ASLEEP 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence 20.1/25 ROCE 29.5% · OPM 28% 76% evidence 13.2/20 P/E 18.8× · PEG — 50% evidence 11.1/20 RS sector 2.2% · RS bench -3.2% · 1Y -4.9%0 of 10 weeks ahead 70% evidence
Exact sum: 19 + 20.1 + 13.2 + 11.1 = 63.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
5Aeroflex Enterprises LtdAEROENTER 62.5/100Mixed-positive evidence87% evidence LEADER 19.7/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence 14.7/25 ROCE 12.6% · OPM 9% 95% evidence 8.9/20 P/E 9.5× · PEG — 50% evidence 19.2/20 RS sector 36.3% · RS bench 34.8% · 1Y 32.4%12 of 12 weeks ahead 100% evidence
Exact sum: 19.7 + 14.7 + 8.9 + 19.2 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
6Take Solutions Ltdthis pageTAKE 58.7/100Thin evidence · provisional57% evidence 24.7/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence 8.5/25 ROCE 11.2% · OPM — 80% evidence 8.5/20 P/E 3222× · PEG — 15% evidence 17.0/20 RS sector 71.1% · RS bench 71.4% · 1Y 384%11 of 12 weeks ahead to 2026-05-03 70% evidence
Exact sum: 24.7 + 8.5 + 8.5 + 17 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
7Global Education LtdGLOBAL 57.8/100Mixed-positive evidence80% evidence ASLEEP 14.2/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence 19.8/25 ROCE 29.2% · OPM 41% 95% evidence 10.3/20 P/E 20.8× · PEG — 15% evidence 13.5/20 RS sector 16.7% · RS bench 16% · 1Y 63%0 of 12 weeks ahead 100% evidence
Exact sum: 14.2 + 19.8 + 10.3 + 13.5 = 57.8 · Decision use: Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation.
8GMR Airports LtdGMRAIRPORT 56.6/100Mixed-positive evidence74% evidence FADING 22.7/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence 11.3/25 ROCE 11.6% · OPM 37% 100% evidence 8.7/20 P/E 191× · PEG — 15% evidence 13.9/20 RS sector 2.6% · RS bench 1.9% · 1Y 14.3%8 of 12 weeks ahead 100% evidence
Exact sum: 22.7 + 11.3 + 8.7 + 13.9 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
9R K Swamy LtdRKSWAMY 56.5/100Mixed-positive evidence65% evidence FADING 22.5/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence 15.3/25 ROCE 12.3% · OPM 10.4% 95% evidence 10.4/20 P/E 19.5× · PEG — 15% evidence 8.3/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead 25% evidence
Exact sum: 22.5 + 15.3 + 10.4 + 8.3 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
10Aegis Vopak Terminals LtdAEGISVOPAK 56.1/100Mixed-positive evidence60% evidence BREAKING OUT 21.9/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence 13.2/25 ROCE 7.6% · OPM 77% 76% evidence 9.2/20 P/E 110× · PEG — 15% evidence 11.8/20 RS sector — · RS bench 12% · 1Y 9%7 of 10 weeks ahead 25% evidence
Exact sum: 21.9 + 13.2 + 9.2 + 11.8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
11Inox Green Energy Services LtdINOXGREEN 54.1/100Mixed-positive evidence75% evidence FADING 22.2/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence 9.1/25 ROCE 8.4% · OPM -2.2% 76% evidence 9.6/20 P/E 61.3× · PEG — 15% evidence 13.2/20 RS sector 0.5% · RS bench -0.3% · 1Y 24.2%8 of 12 weeks ahead 100% evidence
Exact sum: 22.2 + 9.1 + 9.6 + 13.2 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
12Parin Enterprises LtdPARIN 53.7/100Mixed-positive evidence63% evidence BREAKING OUT 19.4/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence 11.6/25 ROCE 10.8% · OPM 9% 95% evidence 8.8/20 P/E 124× · PEG — 15% evidence 13.9/20 RS sector 15.7% · RS bench 15% · 1Y 76.3%9 of 12 weeks ahead 100% evidence
Exact sum: 19.4 + 11.6 + 8.8 + 13.9 = 53.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
13Anzen India Energy Yield Plus TrustANZEN 50.5/100Mixed-positive evidence60% evidence FADING 20.7/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence 9.1/25 ROCE 3.3% · OPM 80% 76% evidence 9.3/20 P/E 102× · PEG — 15% evidence 11.4/20 RS sector — · RS bench 7.3% · 1Y 14.1%2 of 10 weeks ahead 25% evidence
Exact sum: 20.7 + 9.1 + 9.3 + 11.4 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
14Eveready Industries India LtdEVEREADY 50.1/100Mixed-positive evidence94% evidence TURNING 18.9/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence 13.6/25 ROCE 17.2% · OPM 15% 100% evidence 8.8/20 P/E 16.3× · PEG 2.1 100% evidence 8.8/20 RS sector -9.5% · RS bench 1% · 1Y -12.8%5 of 10 weeks ahead 70% evidence
Exact sum: 18.9 + 13.6 + 8.8 + 8.8 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
15Jai Corp LtdJAICORPLTD 49.8/100Mixed-negative evidence74% evidence ASLEEP 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence 12.7/25 ROCE 13.3% · OPM 15% 95% evidence 10.8/20 P/E 18.7× · PEG — 15% evidence 6.7/20 RS sector -8.2% · RS bench -20% · 1Y -6.5%4 of 10 weeks ahead 70% evidence
Exact sum: 19.6 + 12.7 + 10.8 + 6.7 = 49.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
16TCC Concept LtdTCC 47.2/100Mixed-negative evidence81% evidence ASLEEP 16.6/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence 11.8/25 ROCE 5.7% · OPM 36% 95% evidence 14.3/20 P/E 18.7× · PEG — 50% evidence 4.5/20 RS sector -17.6% · RS bench -40.7% · 1Y -48.8%0 of 11 weeks ahead 70% evidence
Exact sum: 16.6 + 11.8 + 14.3 + 4.5 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
17Jindal Photo LtdJINDALPHOT 46.6/100Mixed-negative evidence77% evidence ASLEEP 20.4/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence 10.1/25 ROCE -1.4% · OPM 98% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 6.1/20 RS sector -14.8% · RS bench -15.1% · 1Y 26.3%1 of 12 weeks ahead 100% evidence
Exact sum: 20.4 + 10.1 + 10 + 6.1 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
18Aqylon Nexus LtdAQYLON 45.9/100Mixed-negative evidence72% evidence ASLEEP 18.5/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence 18.8/25 ROCE 131% · OPM 58% 95% evidence 8.6/20 P/E 819× · PEG — 15% evidence 0.0/20 RS sector -76% · RS bench -76% · 1Y -80.8%0 of 12 weeks ahead 100% evidence
Exact sum: 18.5 + 18.8 + 8.6 + 0 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
19Shipping Corporation of India Land & Assets LtdSCILAL 42.9/100Mixed-negative evidence80% evidence ASLEEP 24.2/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence 5.0/25 ROCE 1.3% · OPM -14% 95% evidence 9.4/20 P/E 65.9× · PEG — 15% evidence 4.3/20 RS sector -13.8% · RS bench -14.3% · 1Y -17.8%2 of 12 weeks ahead 100% evidence
Exact sum: 24.2 + 5 + 9.4 + 4.3 = 42.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.8% and the one-year return is -17.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth.
20TruAlt Bioenergy LtdTRUALT 40.1/100Mixed-negative evidence63% evidence TURNING 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence 9.3/25 ROCE 10.4% · OPM 21% 100% evidence 10.1/20 P/E 26.4× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence
Exact sum: 10.7 + 9.3 + 10.1 + 10 = 40.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
21GKW LtdGKWLIMITED 39.2/100Mixed-negative evidence71% evidence ASLEEP 10.9/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence 9.2/25 ROCE 0.5% · OPM 84% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 9.1/20 RS sector -0.9% · RS bench -6.6% · 1Y -2.4%3 of 10 weeks ahead 70% evidence
Exact sum: 10.9 + 9.2 + 10 + 9.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
22Unitech LtdUNITECH 36.3/100Mixed-negative evidence69% evidence ASLEEP 18.0/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence 3.5/25 ROCE 0.1% · OPM 6% 95% evidence 10.0/20 P/E — · PEG — 0% evidence 4.8/20 RS sector -28.9% · RS bench -29.3% · 1Y -42.7%3 of 12 weeks ahead 100% evidence
Exact sum: 18 + 3.5 + 10 + 4.8 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
23Kaveri Seed Company LtdKSCL 36.0/100Mixed-negative evidence94% evidence ASLEEP 11.3/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence 14.4/25 ROCE 18.8% · OPM 40% 100% evidence 4.9/20 P/E 16.1× · PEG 3.12 100% evidence 5.4/20 RS sector -17.2% · RS bench -18.3% · 1Y -27.6%3 of 11 weeks ahead 70% evidence
Exact sum: 11.3 + 14.4 + 4.9 + 5.4 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
24Delta Corp LtdDELTACORP 35.5/100Mixed-negative evidence81% evidence ASLEEP 9.7/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence 8.6/25 ROCE 5% · OPM 18% 95% evidence 11.9/20 P/E 10.5× · PEG — 50% evidence 5.3/20 RS sector -18.1% · RS bench -14.3% · 1Y -26.9%5 of 10 weeks ahead 70% evidence
Exact sum: 9.7 + 8.6 + 11.9 + 5.3 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
25Prozone Realty LtdPROZONER 34.7/100Adverse evidence80% evidence ASLEEP 17.0/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence 6.4/25 ROCE -1% · OPM -35.6% 95% evidence 9.5/20 P/E 62.1× · PEG — 15% evidence 1.8/20 RS sector -19.6% · RS bench -20% · 1Y -3.6%2 of 12 weeks ahead 100% evidence
Exact sum: 17 + 6.4 + 9.5 + 1.8 = 34.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
26Stanley Lifestyles LtdSTANLEY 29.9/100Adverse evidence74% evidence ASLEEP 6.6/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence 10.8/25 ROCE 6.4% · OPM 17.3% 95% evidence 9.1/20 P/E 113× · PEG — 15% evidence 3.4/20 RS sector -43.7% · RS bench -32% · 1Y -56.2%3 of 10 weeks ahead 70% evidence
Exact sum: 6.6 + 10.8 + 9.1 + 3.4 = 29.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
27Embassy Developments LtdEMBDL 28.1/100Adverse evidence64% evidence ASLEEP 5.9/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence 3.4/25 ROCE -2.4% · OPM -60% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 8.8/20 RS sector -12% · RS bench -12.7% · 1Y -35.7%7 of 12 weeks ahead 100% evidence
Exact sum: 5.9 + 3.4 + 10 + 8.8 = 28.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
28RattanIndia Enterprises LtdRTNINDIA 17.6/100Adverse evidence74% evidence ASLEEP 2.7/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence 1.0/25 ROCE -4.8% · OPM 2.1% 100% evidence 10.0/20 P/E — · PEG — 0% evidence 3.9/20 RS sector -32.1% · RS bench -25.1% · 1Y -41.7%5 of 10 weeks ahead 70% evidence
Exact sum: 2.7 + 1 + 10 + 3.9 = 17.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
29Central Mine Planning & Design Institute LtdCMPDI 62.4/100Thin evidence · provisional38% evidence ASLEEP 22.1/35 Revenue — · PAT — · OPM change 8 pp 32% evidence 20.1/25 ROCE 38.1% · OPM 30% 95% evidence 10.2/20 P/E 25.9× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —4 of 5 weeks ahead 0% evidence
Exact sum: 22.1 + 20.1 + 10.2 + 10 = 62.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
30FlySBS Aviation LtdFLYSBS 54.8/100Thin evidence · provisional41% evidence TURNING 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence 19.4/25 ROCE 32.5% · OPM 21% 95% evidence 11.2/20 P/E 12.6× · PEG — 15% evidence 8.8/20 RS sector — · RS bench -12.2% · 1Y -1.6%3 of 10 weeks ahead 25% evidence
Exact sum: 15.4 + 19.4 + 11.2 + 8.8 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
31Qualitek Labs Ltd544091 53.5/100Thin evidence · provisional29% evidence TURNING 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence 14.8/25 ROCE 11.9% · OPM 26% 76% evidence 9.9/20 P/E 34× · PEG — 15% evidence 11.5/20 RS sector — · RS bench 8.5% · 1Y —2 of 2 weeks ahead 25% evidence
Exact sum: 17.3 + 14.8 + 9.9 + 11.5 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
32Shree Vasu Logistics LtdSVLL 52.0/100Thin evidence · provisional50% evidence BREAKING OUT 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence 15.8/25 ROCE 12.9% · OPM 25.8% 95% evidence 8.9/20 P/E 121× · PEG — 15% evidence 9.0/20 RS sector -16.1% · RS bench 9.8% · 1Y -4.4%10 of 10 weeks ahead 70% evidence
Exact sum: 18.3 + 15.8 + 8.9 + 9 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
33Maagh Advertising & Marketing Services Ltd543624 49.8/100Thin evidence · provisional35% evidence 18.4/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence 9.1/25 ROCE -0.4% · OPM 55.6% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 12.3/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence
Exact sum: 18.4 + 9.1 + 10 + 12.3 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
34Indiqube Spaces LtdINDIQUBE 47.3/100Thin evidence · provisional49% evidence TURNING 18.9/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence 9.3/25 ROCE 6.4% · OPM 61% 76% evidence 10.0/20 P/E — · PEG — 0% evidence 9.1/20 RS sector — · RS bench -6.3% · 1Y -16.7%2 of 10 weeks ahead 25% evidence
Exact sum: 18.9 + 9.3 + 10 + 9.1 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
35Tandhan Industries Ltd512062 46.6/100Thin evidence · provisional33% evidence BREAKING OUT 20.2/35 Revenue — · PAT 100% · OPM change — 33% evidence 6.7/25 ROCE -0.3% · OPM 15.8% 76% evidence 9.7/20 P/E 60.6× · PEG — 15% evidence 10.0/20 RS sector — · RS bench — · 1Y —6 of 6 weeks ahead 0% evidence
Exact sum: 20.2 + 6.7 + 9.7 + 10 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
36Shree Rama Newsprint LtdRAMANEWS 45.0/100Thin evidence · provisional46% evidence 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence 6.1/25 ROCE 1.9% · OPM 8% 71% evidence 10.0/20 P/E — · PEG — 0% evidence 14.8/20 RS sector 9.7% · RS bench 10.5% · 1Y 9.2%11 of 12 weeks ahead to 2026-04-19 70% evidence
Exact sum: 14.1 + 6.1 + 10 + 14.8 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.

Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.

15 · Frequently asked questions

Frequently asked questions

What is Take Solutions Ltd's share price today?

Take Solutions Ltd trades at ₹43.6, +444.5% over the past year. The company is valued at ₹644 Cr. The stock sits at 87% of its 52-week range of ₹7–₹49, +35.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 29 weeks in. — as of 14 August 2026.

What were Take Solutions Ltd's latest quarterly results?

Take Solutions Ltd reported revenue of ₹0.0 Cr and net profit of ₹1.1 Cr for the Dec 25 quarter. Earnings per share were ₹0.08. — as of 14 August 2026.

What is Take Solutions Ltd's revenue?

Take Solutions Ltd reported revenue of ₹0.0 Cr in the Dec 25 quarter. For the full FY25 fiscal year, revenue was ₹0.0 Cr (−100.0%). — as of 14 August 2026.

What is Take Solutions Ltd's profit?

Take Solutions Ltd earned ₹1.1 Cr of net profit in the Dec 25 quarter, −97.7% year on year. Full-year FY25 profit was ₹37.5 Cr. — as of 14 August 2026.

What is Take Solutions Ltd's market cap?

Take Solutions Ltd's market capitalisation is ₹644 Cr at a share price of ₹43.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.

What is Take Solutions Ltd's P/E ratio?

Take Solutions Ltd trades at a P/E of 3,222.0×, at the most expensive it has been in 10 years, against a long-run median of 13.4×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.

Does Take Solutions Ltd pay a dividend?

Not in its latest year — Take Solutions Ltd's dividend payout was 0% of profit in FY25. It did record a payout in 6 of its last 12 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.

Is Take Solutions Ltd overvalued?

On its own history, Take Solutions Ltd looks expensive: its P/E of 3,222.0× sits at the most expensive it has been in 10 years (long-run median 13.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.

How is Take Solutions Ltd performing?

Take Solutions Ltd is in a confirmed uptrend, 29 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 45 weeks. This describes what the data did, not a rating. — as of 14 August 2026.

Is Take Solutions Ltd in an uptrend?

Yes — the price is in a confirmed uptrend (week 29 of stage 2), trading +35.1% versus its 200-day average and at 87% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.

Is Take Solutions Ltd beating the market?

On recent form, yes — Take Solutions Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 45 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved −67% against the NIFTY 500's +277% — behind the index over the full window. — as of 14 August 2026.

Will Take Solutions Ltd's share price go up?

This page publishes no price forecast for Take Solutions Ltd. What it measures instead: the share price is ₹43.6, the price is in a confirmed uptrend 29 weeks in. Its P/E of 3,222.0× sits at the 100th percentile of its own 10-year range. — as of 14 August 2026.

Who owns Take Solutions Ltd?

Promoters hold 0.0% of Take Solutions Ltd, foreign institutions 0.3%, domestic institutions 0.0% and the public 99.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 53.4 points over 8 quarters. — as of 14 August 2026.

Does Take Solutions Ltd have too much debt?

No — Take Solutions Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill −4×. FY25 borrowings were ₹0.0 Cr against equity of ₹20.5 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.

What is Take Solutions Ltd's capex?

Take Solutions Ltd spent ₹−87.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹−30.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.

What is Take Solutions Ltd's cash flow?

Take Solutions Ltd consumed ₹16.4 Cr of operating cash in FY25 — cash flowed out rather than in (free cash flow: ₹14.0 Cr). Operating cash was negative while the company reported a profit of ₹37.5 Cr. Cash-flow resolution for India is annual. — as of 14 August 2026.

Is Take Solutions Ltd's profit real cash?

Not fully — over the last 3 fiscal years, 55% of Take Solutions Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹−16.4 Cr against reported profit of ₹37.5 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 14 August 2026.

Where is Take Solutions Ltd in its business cycle?

Take Solutions Ltd's FY25 operating margin was −227.8%, against a 12-year band of −568.9%–20.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.

What could break the Take Solutions Ltd story?

Biggest watch item: the P/E sits at the 100th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.

Is Take Solutions Ltd a stock worth studying right now?

This is not investment advice. The machine read: Take Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.

Chat with this pageChat with pageChatChatGPTClaudePerplexityGoogle AI